A recent report from the National Restaurant Association highlights how GLP-1 weight-loss drugs are reshaping beverage choices in restaurants. As health consciousness rises, particularly among younger consumers, many are opting for wellness drinks and non-alcoholic alternatives,…
Hims & Hers Health has reported a larger-than-expected loss in the second quarter, attributed to its transition towards branded weight-loss drugs. Despite the financial setback, t…
The death of 19-year-old Josephine Nasr, a law student in London, has sparked serious concerns regarding the safety of tirzepatide, a GLP-1 weight loss drug. Following her prescri…
Nestle is leveraging the rise of GLP-1 weight-loss drugs to create new products aimed at consumers taking medications like Ozempic and Wegovy. The company is utilizing artificial…
As bodybuilders increasingly turn to banned peptides like GHK-Cu and Retatrutide for perceived benefits such as improved skin and reduced hunger, experts warn of significant healt…
A recent study from Yale University has uncovered a surprising mechanism by which GLP-1 therapies, like Ozempic, support sustained weight loss. Contrary to previous beliefs that t…
A recent study published in JAMA Network Open found that a low-fat vegan diet can lead to weight loss comparable to the injectable medication semaglutide over a 16-week period. Pa…
As the yogurt aisle becomes increasingly competitive with high-protein options, experts warn consumers to consider more than just protein content, especially those using GLP-1 med…
As the popularity of GLP-1 weight-loss drugs grows, body acceptance becomes increasingly challenging, particularly in a social media landscape filled with weight-loss marketing. E…
A recent study from the University of Copenhagen highlights the significant role of exercise in enhancing cardiovascular health among individuals with severe obesity, even after s…
A recent analysis published in the British Medical Journal scrutinizes the effectiveness of popular obesity medications like Wegovy and Mounjaro, revealing that while these drugs…
A recent study reveals that UK households using weight-loss medications like Wegovy and Mounjaro are spending significantly less on groceries, with an average reduction of £418 in…
In a bold move to align with modern wellness trends, L'Oreal is developing skincare products specifically designed for users of weight-loss drugs, navigating the turbulent waters…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
The Federal Reserve's latest Beige Book indicates a modest increase in US economic activity, slight employment growth, and moderate price increases. The report highlights mixed se…